In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Regulus Therapeutics Inc (NASDAQ: RGLS) closed at $2.43 in the last session, down -8.30% from day before closing price of $2.65. In other words, the price has decreased by -$8.30 from its previous closing price. On the day, 0.89 million shares were traded. RGLS stock price reached its highest trading level at $2.789 during the session, while it also had its lowest trading level at $2.4.
Ratios:
We take a closer look at RGLS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 18, 2024, initiated with a Outperform rating and assigned the stock a target price of $6.
On March 28, 2018, B. Riley FBR Inc. started tracking the stock assigning a Neutral rating and target price of $1.
On January 05, 2018, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $2.Leerink Partners initiated its Outperform rating on January 05, 2018, with a $2 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 18 ’24 when Hagan Joseph P sold 14,580 shares for $1.19 per share. The transaction valued at 17,359 led to the insider holds 57,112 shares of the business.
CALSADA CRISPINA sold 5,468 shares of RGLS for $6,510 on Jan 18 ’24. The Chief Financial Officer now owns 5,782 shares after completing the transaction at $1.19 per share. On Jan 18 ’24, another insider, Aker Christopher Ray, who serves as the Sr. VP & General Counsel of the company, sold 5,468 shares for $1.19 each. As a result, the insider received 6,510 and left with 10,056 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGLS now has a Market Capitalization of 173482800 and an Enterprise Value of 138420560.
Stock Price History:
Over the past 52 weeks, RGLS has reached a high of $3.79, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 6.76%, while the 200-Day Moving Average is calculated to be 51.95%.
Shares Statistics:
According to the various share statistics, RGLS traded on average about 3.10M shares per day over the past 3-months and 275180 shares per day over the past 10 days. A total of 65.47M shares are outstanding, with a floating share count of 57.42M. Insiders hold about 12.29% of the company’s shares, while institutions hold 25.01% stake in the company. Shares short for RGLS as of 1713139200 were 6274945 with a Short Ratio of 2.02, compared to 1710460800 on 5129655. Therefore, it implies a Short% of Shares Outstanding of 6274945 and a Short% of Float of 12.1800005.
